iBio, Inc. (IBIO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.08M | -5.24M | -5.67M | -4.62M | -3.1M | -3.87M | -3.71M | -4.85M | -3.65M | -4.71M | -5.34M | -4.97M |
| Operating CF Margin % | - | - | -5665% | -2307.5% | - | -1934.5% | - | -2773.71% | - | - | -10680% | - |
| Operating CF Growth % | -95.94% | -35.46% | -52.49% | 4.92% | 15.02% | 17.79% | 30.43% | 2.33% | 5.63% | 38.36% | 61.75% | 57.97% |
| Net Income | -7.73M | -8.99M | -5.72M | -5.16M | -4.86M | -4.36M | -3.99M | -7.78M | -2.63M | -8.21M | -5.75M | -6.03M |
| Depreciation & Amortization | 250K | -211K | 289K | 285K | 282K | 281K | 278K | 281K | 332K | 319K | 318K | 305K |
| Stock-Based Compensation | 0 | 253K | 323K | 270K | 370K | 475K | 415K | 360K | 0 | 456K | 765K | 446K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.1M | 0 | 0 |
| Other Non-Cash Items | 2.79M | 2.92M | -28K | -15K | -14K | -14K | -19K | 4.53M | -1.25M | -250K | 18K | 322K |
| Working Capital Changes | -1.39M | 792K | -529K | 8K | 1.12M | -247K | -400K | -2.25M | -105K | -120K | -695K | -10K |
| Change in Receivables | 0 | 0 | -65K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 380K | -29K | 495K | 712K | 863K | -241K | 497K | -870K | -632K | -51K | 62K | -144K |
| Cash from Investing | -3.11M | -2.98M | -21.49M | 45K | -14K | -2K | 713K | -144K | 1M | 0 | 50K | -6K |
| Capital Expenditures | -11K | -516K | -32K | -1K | -14K | -1K | 0 | -210K | 0 | 0 | 0 | -506K |
| CapEx % of Revenue | - | - | 32% | 0.5% | - | 0.5% | - | 120% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -3.1M | 21.46M | 0 | 46K | 0 | -1K | 713K | 66K | 1M | 0 | 50K | 500K |
| Cash from Financing | 28.15M | 8.79M | 46.7M | 8.18M | 1.06M | -152K | -162K | 12.99M | 5.03M | 4M | 2.47M | 2.74M |
| Debt Issued (Net) | 0 | -614K | -160K | -183K | -176K | -170K | -166K | -1.24M | 748K | -107K | -540K | -896K |
| Equity Issued (Net) | 28.15M | 9.4M | 46.76M | 2.41M | 1.13M | 18K | 4K | 14.23M | 4.28M | 4.12M | 2.81M | 3.64M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7K | 0 | 0 |
| Other Financing | 0 | 0 | 105K | 5.95M | 112K | 0 | 0 | -1K | 0 | -7K | 204K | 0 |
| Net Change in Cash | 18.96M | 561K | 19.53M | 3.61M | -2.06M | -4.02M | -3.16M | 7.99M | 2.37M | -701K | -2.82M | -2.24M |
| Free Cash Flow | -6.09M | -5.76M | -5.7M | -4.62M | -3.12M | -3.87M | -3.71M | -5.06M | -3.65M | -4.71M | -5.34M | -5.48M |
| FCF Margin % | - | - | -5697% | -2308% | - | -1935% | - | -2893.71% | - | - | -10680% | - |
| FCF Growth % | -95.42% | -48.76% | -53.35% | 8.85% | 14.64% | 17.76% | 30.43% | 7.52% | 0.46% | 55.56% | 67.51% | 64.1% |
| FCF per Share | -0.05 | -0.06 | -0.11 | -0.28 | -0.32 | -0.42 | -0.43 | -0.59 | -0.98 | -2.54 | -4.46 | -5.39 |
| FCF Conversion (FCF/Net Income) | 0.79x | 0.58x | 0.99x | 0.89x | 0.64x | 0.89x | 0.93x | 0.62x | 1.15x | 0.57x | 0.93x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 44K | 54K | 0 | 0 | 0 | 0 | 0 | 200K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |